top of page
enter here
Ketamine to Prevent PPD After Cesarean
About the study
NCT Trial Number
NCT04227704
The drug being studied
Ketamine
Sponsored by
Washington University School of Medicine
Trial Start Date
Aug-20
About the participants
Age seeking
18 Years to 45 Years
gender
Female
Primary condition of volunteers accepted
Postpartum Depression
Accepts healthy volunteers?
No
This study explores the potential of administering IV or subcutaneous ketamine after a caesarean section, to reduce the risk of developing post partum depression.
Locations
United States, Missouri
Washington University in St. Louis
Saint Louis, Missouri, United States, 63110
Contact: Ben Swan
314-273-8257
bswan@wustl.edu
Contact: Kristi Kraus, RN
314-273-7921
kristinkraus@wustl.edu
bottom of page